Catalyst Wire Dossier Catalyst Wire Dossier

Teriflunomide

teriflunomide · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

67 regulatory and trial events tracked for Teriflunomide, covering 2012-10-04 to 2026-06-11. Get the full timeline:

Most recent: EMA Authorised: Teriflunomide Viatris (previously Teriflunomide Mylan) (teriflunomide) — Viatris Limited

See pricing